Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/15/26 19:57 | 6/12/26 | IPSC | Health | BioPrd | Biological Products, (No Diag | Russotti Gregory | PA | O | See Rema | 8 | S.d | -36 | 2.05 | 0 | -18 | 618 | D | |||||||||||||||
6/15/26 19:56 | 6/12/26 | IPSC | Health | BioPrd | Biological Products, (No Diag | Carr Douglas | PA | O | SVP Fina | 13 | S.d | -29 | 1.65 | 0 | -17 | 515 | D | |||||||||||||||
11/24/25 16:05 | 11/20/25 | IPSC | Health | BioPrd | Biological Products, (No Diag | Cowan Chad | PA | O | Chief Sc | 1 | S | -3 | 0.5009 | 0 | -5 | 998 | D | |||||||||||||||
11/19/25 16:19 | 11/17/25 | IPSC | Health | BioPrd | Biological Products, (No Diag | Pfeiffenberger Brent | PA | DO | P,CEO | 5 | S.d | -33 | 0.5028 | 0 | -65 | 3,269 | D | |||||||||||||||
6/11/25 17:05 | 6/9/25 | IPSC | Health | BioPrd | Biological Products, (No Diag | Farid Adrienne | PA | O | Chief Op | 3 | S.d | -2 | 0.5990 | 0 | -4 | 252 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |